130 related articles for article (PubMed ID: 28552863)
1. Atrial Natriuretic Peptide　- Old But New Therapeutic in Cardiovascular Diseases.
Ichiki T; Burnett JC
Circ J; 2017 Jun; 81(7):913-919. PubMed ID: 28552863
[TBL] [Abstract][Full Text] [Related]
2. Natriuretic peptide pathways in heart failure: further therapeutic possibilities.
Sangaralingham SJ; Kuhn M; Cannone V; Chen HH; Burnett JC
Cardiovasc Res; 2023 Feb; 118(18):3416-3433. PubMed ID: 36004816
[TBL] [Abstract][Full Text] [Related]
3. Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides.
Ichiki T; Huntley BK; Sangaralingham SJ; Burnett JC
JACC Heart Fail; 2015 Sep; 3(9):715-23. PubMed ID: 26362447
[TBL] [Abstract][Full Text] [Related]
4. Cardiac natriuretic peptides.
Goetze JP; Bruneau BG; Ramos HR; Ogawa T; de Bold MK; de Bold AJ
Nat Rev Cardiol; 2020 Nov; 17(11):698-717. PubMed ID: 32444692
[TBL] [Abstract][Full Text] [Related]
5. The natriuretic peptides in heart failure: diagnostic and therapeutic potentials.
Chen HH; Burnett JC
Proc Assoc Am Physicians; 1999; 111(5):406-16. PubMed ID: 10519161
[TBL] [Abstract][Full Text] [Related]
6. Atrial Natriuretic Peptide: A Molecular Target of Novel Therapeutic Approaches to Cardio-Metabolic Disease.
Cannone V; Cabassi A; Volpi R; Burnett JC;
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269783
[TBL] [Abstract][Full Text] [Related]
7. Three molecular forms of atrial natriuretic peptides: quantitative analysis and biological characterization.
Nagai-Okatani C; Kangawa K; Minamino N
J Pept Sci; 2017 Jul; 23(7-8):486-495. PubMed ID: 28120499
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, Not NPR-A, is the predominant natriuretic peptide receptor in the failing heart.
Dickey DM; Flora DR; Bryan PM; Xu X; Chen Y; Potter LR
Endocrinology; 2007 Jul; 148(7):3518-22. PubMed ID: 17412809
[TBL] [Abstract][Full Text] [Related]
9. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
[TBL] [Abstract][Full Text] [Related]
10. Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure.
Martin FL; Stevens TL; Cataliotti A; Schirger JA; Borgeson DD; Redfield MM; Luchner A; Burnett JC
Kidney Int; 2005 May; 67(5):1723-30. PubMed ID: 15840018
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: a 9-year follow-up study.
Cannone V; Huntley BK; Olson TM; Heublein DM; Scott CG; Bailey KR; Redfield MM; Rodeheffer RJ; Burnett JC
Hypertension; 2013 Nov; 62(5):860-5. PubMed ID: 24041948
[TBL] [Abstract][Full Text] [Related]
12. Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases.
Tremblay J; Desjardins R; Hum D; Gutkowska J; Hamet P
Mol Cell Biochem; 2002 Jan; 230(1-2):31-47. PubMed ID: 11952095
[TBL] [Abstract][Full Text] [Related]
13. Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats.
Tremblay J; Huot C; Willenbrock RC; Bayard F; Gossard F; Fujio N; Koch C; Kuchel O; Debinski W; Hamet P
J Clin Invest; 1993 Nov; 92(5):2499-508. PubMed ID: 7901238
[TBL] [Abstract][Full Text] [Related]
14. Depressed Corin Levels Indicate Early Systolic Dysfunction Before Increases of Atrial Natriuretic Peptide/B-Type Natriuretic Peptide and Heart Failure Development.
Tripathi R; Wang D; Sullivan R; Fan TH; Gladysheva IP; Reed GL
Hypertension; 2016 Feb; 67(2):362-7. PubMed ID: 26667411
[TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic peptide and regulation of vascular function in hypertension and heart failure: implications for novel therapeutic strategies.
Rubattu S; Calvieri C; Pagliaro B; Volpe M
J Hypertens; 2013 Jun; 31(6):1061-72. PubMed ID: 23524910
[TBL] [Abstract][Full Text] [Related]
16. Congestive heart failure: increased cardiac and extracardiac atrial natriuretic peptide gene expression.
Poulos JE; Gower WR; Sullebarger JT; Fontanet HL; Vesely DL
Cardiovasc Res; 1996 Nov; 32(5):909-19. PubMed ID: 8944822
[TBL] [Abstract][Full Text] [Related]
17. Localization of corin and atrial natriuretic peptide expression in human renal segments.
Dong L; Wang H; Dong N; Zhang C; Xue B; Wu Q
Clin Sci (Lond); 2016 Sep; 130(18):1655-64. PubMed ID: 27343265
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
[TBL] [Abstract][Full Text] [Related]
19. The relaxation induced by uroguanylin and the expression of natriuretic peptide receptors in human corpora cavernosa.
Sousa CM; Havt A; Santos CF; Arnaud-Batista FJ; Cunha KM; Cerqueira JB; Fonteles MC; Nascimento NR
J Sex Med; 2010 Nov; 7(11):3610-9. PubMed ID: 20102442
[TBL] [Abstract][Full Text] [Related]
20. [Natriuretic peptide family].
Hirata Y
Nihon Rinsho; 1993 May; 51(5):1156-64. PubMed ID: 8392634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
